Search

everythinglearnresearchcommunity

for

Search:↓

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

Cetuximab can cause unusual hair growth and hair loss.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Melatonin stops melanin production after tyrosinase action, with cyclic GMP mimicking this effect.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

Glibenclamide slows breast cancer cell growth by stopping cell division.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.